A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

Summary

This study is being done to look at how well a study medicine called CagriSema helps people with diabetes lower their blood sugar. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. The study will last for about 38 weeks.

Timeline

Start

2026-08-27

Primary completion

2027-08-25

Completion

2027-10-13

Drugs

Indications